Novo Nordisk A/S (NVO)

Add to Watchlists
Create an Alert
Quickflows
82.28 -0.49  -0.59% NYSE Jun 18, 20:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All NVO News

News

View All Events

Events

Date Type Description
08/05/2021 Earnings Results Q2 2021 Earnings Results
08/05/2021 Earnings Calls Q2 2021 Earnings Call
05/05/2021 Earnings Results Q1 2021 Earnings Results
05/05/2021 07:00 EST Earnings Calls Q1 2021 Earnings Call
03/26/2021 Dividends 0.9221 Normal dividend, declared February 23, 2021 and paid April 07, 2021
03/25/2021 09:00 EST AGM 2020 Annual General Meeting
02/03/2021 Earnings Results Q4 2020 Earnings Results
02/03/2021 07:00 EST Earnings Calls Q4 2020 Earnings Call
10/30/2020 Earnings Results Q3 2020 Earnings Results
08/14/2020 Dividends 0.5178 Normal dividend, declared August 01, 2020 and paid August 25, 2020
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 19.92B
Total Expenses (TTM) 11.64B
Net Income (TTM) 6.726B

Balance Sheet View Statement

Total Assets (Quarterly) 22.29B
Total Liabilities (Quarterly) 13.07B
Shareholders Equity (Quarterly) 9.220B

Cash Flow Statement View Statement

Cash from Operations (TTM) 8.306B
Cash from Investing (TTM) -3.691B
Cash from Financing (TTM) -5.293B

Ratings & Reports

Advertisement
Edit

Profile

  • Description: With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
  • URL: http://www.novonordisk.com
  • Investor Relations URL: https://www.novonordisk.com/investors.html
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Aug. 05, 2021
  • Last Earnings Release: May. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Mar. 26, 2021

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 82.28
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
PPH VanEck Vectors Pharmaceutical ETF 5.50%
LIFE.TO Evolve Global Healthcare Enh Yld ETF Hdg 4.86%
CCWSX Chautauqua International Growth Investor 4.24%
BMO40719 BMO European F (USD) 4.01%
CCM2510 IA Clarington US Eq Ccy Netrl Ser I 2.77%
AMIGX Amana Growth Institutional 2.62%
PGRCX BNY Mellon Worldwide Growth C 1.97%
JTD Nuveen Tax-Adv Div Growth 1.43%
PQIRX Pioneer Equity Income R 1.31%
FDIV First Trust Strategic Income ETF 0.82%
PTIN Pacer Trendpilot International ETF 0.79%
AVDE Avantis® International Equity ETF 0.51%

Comparables

Edit
LLY Eli Lilly and Co
GMAB Genmab A/S
FWP Forward Pharma A/S
ASND Ascendis Pharma A/S
ZEAL Zealand Pharma A/S

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.